| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XENE | Common Shares | Sale | -$696K | -18K | -32.73% | $38.63 | 37K | May 30, 2023 | Direct | F1 |
| transaction | XENE | Common Shares | Sale | -$758K | -19K | -51.35% | $39.90 | 18K | May 30, 2023 | Direct | F2 |
| transaction | XENE | Common Shares | Sale | -$462K | -12K | -66.67% | $38.53 | 6K | May 31, 2023 | Direct | F3 |
| transaction | XENE | Common Shares | Options Exercise | $294K | +29.8K | +497.25% | $9.85* | 35.8K | May 31, 2023 | Direct | F4 |
| transaction | XENE | Common Shares | Tax liability | -$237K | -6.17K | -17.2% | $38.37 | 29.7K | May 31, 2023 | Direct | F5 |
| transaction | XENE | Common Shares | Sale | -$919K | -23.7K | -79.78% | $38.81 | 6K | May 31, 2023 | Direct | F6 |
| transaction | XENE | Common Shares | Options Exercise | $888K | +50K | +833.33% | $17.76 | 56K | May 31, 2023 | Direct | |
| transaction | XENE | Common Shares | Tax liability | -$888K | -23.1K | -41.33% | $38.37 | 32.9K | May 31, 2023 | Direct | F5 |
| transaction | XENE | Common Shares | Sale | -$1.04M | -26.9K | -81.74% | $38.69 | 6K | May 31, 2023 | Direct | F7 |
| transaction | XENE | Common Shares | Options Exercise | $71.7K | +9.32K | +155.3% | $7.69* | 15.3K | Jun 1, 2023 | Direct | |
| transaction | XENE | Common Shares | Tax liability | -$71.7K | -1.86K | -12.14% | $38.53 | 13.5K | Jun 1, 2023 | Direct | F8 |
| transaction | XENE | Common Shares | Sale | -$291K | -7.46K | -55.42% | $38.97 | 6K | Jun 1, 2023 | Direct | |
| transaction | XENE | Common Shares | Options Exercise | $799K | +45K | +750% | $17.76 | 51K | Jun 1, 2023 | Direct | |
| transaction | XENE | Common Shares | Tax liability | -$799K | -20.7K | -40.68% | $38.53 | 30.3K | Jun 1, 2023 | Direct | F8 |
| transaction | XENE | Common Shares | Sale | -$941K | -24.3K | -80.17% | $38.78 | 6K | Jun 1, 2023 | Direct | F9 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XENE | Stock Option (Right to Buy) | Options Exercise | $0 | -29.8K | -100% | $0.00* | 0 | May 31, 2023 | Common Shares | 29.8K | $9.85 | Direct | F4, F10 |
| transaction | XENE | Stock Option (Right to Buy) | Options Exercise | $0 | -50K | -52.63% | $0.00 | 45K | May 31, 2023 | Common Shares | 50K | $17.76 | Direct | F10 |
| transaction | XENE | Stock Option (Right to Buy) | Options Exercise | $0 | -9.32K | -23.29% | $0.00 | 30.7K | Jun 1, 2023 | Common Shares | 9.32K | $7.69 | Direct | F10 |
| transaction | XENE | Stock Option (Right to Buy) | Options Exercise | $0 | -45K | -100% | $0.00* | 0 | Jun 1, 2023 | Common Shares | 45K | $17.76 | Direct | F10 |
| Id | Content |
|---|---|
| F1 | The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.50 to $39.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| F2 | The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| F3 | The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.20 to $38.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| F4 | The exercise price was converted to U.S. dollars from $10.78 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. |
| F5 | Represents the closing price of the Company's common shares on May 30, 2023 for purposes of net settlement calculations. |
| F6 | The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.66 to $39.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| F7 | The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.50 to $38.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| F8 | Represents the closing price of the Company's common shares on May 31, 2023 for purposes of net settlement calculations. |
| F9 | The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.78 to $38.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| F10 | The shares subject to the options are fully vested and exercisable. |